News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Seim Robin Gene
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/25/2023 |
4
| Seim Robin Gene (Director) has filed a Form 4 on OMNICELL, INC.
Txns:
| Granted 2,710 shares
@ $0 |
|
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2020 |
4
| Seim Robin Gene (Director) has filed a Form 4 on OMNICELL, Inc
Txns:
| Granted 2,349 shares
@ $0 |
|
05/15/2019 |
4
| Seim Robin Gene (Director) has filed a Form 4 on OMNICELL, Inc
Txns:
| Granted 1,953 shares
@ $0 Granted 6,381 options to buy
@ $81.92, valued at
$522.7k
|
|
05/07/2019 |
4
| Seim Robin Gene (Director) has filed a Form 4 on OMNICELL, Inc
Txns:
| Granted 246 shares
@ $0 |
|
03/20/2019 |
4
| Seim Robin Gene (President, Global A & M A) has filed a Form 4 on OMNICELL, Inc
Txns:
| Disposed of 41,665 shares
@ $0 |
|
03/12/2019 |
4
| Seim Robin Gene (President, Global A & M A) has filed a Form 4 on OMNICELL, Inc
Txns:
| Exercised 28,800 shares
@ $0 Sold 7,296 shares
@ $83.6989, valued at
$610.7k
Sold 21,504 shares
@ $83.6989, valued at
$1.8M
Exercised 13,849 options to buy
@ $44.25, valued at
$612.8k
Exercised 7,165 options to buy
@ $36.7, valued at
$263k
Exercised 5,442 options to buy
@ $27.7, valued at
$150.7k
Exercised 2,344 options to buy
@ $34.02, valued at
$79.7k
|
|
03/06/2019 |
4
| Seim Robin Gene (President, Global A & M A) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 1,129 shares
@ $84.27, valued at
$95.1k
|
|
12/17/2018 |
4
| Seim Robin Gene (President, Global A & M A) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 2,136 shares
@ $0 Paid exercise price by delivering 2,137 shares
@ $0 |
|
06/18/2018 |
4
| Seim Robin Gene (President, Global A & M A) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 4,101 shares
@ $0 |
|
06/04/2018 |
4
| Seim Robin Gene (President, Global A & M A) has filed a Form 4 on OMNICELL, Inc
Txns:
| Exercised 15,658 shares
@ $0 Sold 15,658 shares
@ $48, valued at
$751.6k
Exercised 9,434 options to buy
@ $36.7, valued at
$346.2k
Exercised 1,312 options to buy
@ $36.7, valued at
$48.2k
Exercised 4,912 options to buy
@ $27.7, valued at
$136.1k
|
|
05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/07/2018 |
4
| Seim Robin Gene (President, Global A & M A) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 1,265 shares
@ $0 |
|
02/08/2018 |
4
| Seim Robin Gene (President, Global A & M A) has filed a Form 4 on OMNICELL, Inc
Txns:
| Granted 11,525 shares
@ $0 Granted 13,067 shares
@ $0 Granted 51,136 options to buy
@ $44.25, valued at
$2.3M
|
|
12/18/2017 |
4
| Seim Robin Gene (EVP, Global A & M Adherence) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 2,879 shares
@ $51.75, valued at
$149k
Paid exercise price by delivering 2,223 shares
@ $51.75, valued at
$115k
|
|
09/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2017 |
4
| Seim Robin Gene (EVP, Global A & M Adherence) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 2,073 shares
@ $42.95, valued at
$89k
Paid exercise price by delivering 1,597 shares
@ $42.95, valued at
$68.6k
|
|
03/09/2017 |
4
| Seim Robin Gene (EVP, Global A & M Adherence) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 1,077 shares
@ $0 |
|
02/10/2017 |
4
| Seim Robin Gene (EVP, Global A & M Adherence) has filed a Form 4 on OMNICELL, Inc
Txns:
| Granted 4,190 shares
@ $0 Granted 13,960 shares
@ $0 Granted 34,390 options to buy
@ $36.7, valued at
$1.3M
|
|
12/16/2016 |
4
| Seim Robin Gene (EVP, Global A & M Adherence) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 5,377 shares
@ $33.9, valued at
$182.3k
|
|
07/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/01/2016 |
4
| Seim Robin Gene (EVP, Global A & M Adherence) has filed a Form 4 on OMNICELL, Inc
Txns:
| Exercised 3,645 shares
@ $0 Sold 3,645 shares
@ $35, valued at
$127.6k
Exercised 3,645 options to buy
@ $25.08, valued at
$91.4k
|
|
06/16/2016 |
4
| Seim Robin Gene (EVP, Global A & M Adherence) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 4,199 shares
@ $33.13, valued at
$139.1k
|
|
04/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/26/2016 |
4
| Seim Robin Gene (EVP, Global A & M Adherence) has filed a Form 4 on OMNICELL, Inc
Txns:
| Sold 767 shares
@ $30, valued at
$23k
|
|
03/08/2016 |
4
| Seim Robin Gene (Executive VP, Intl. & Manf.) has filed a Form 4 on OMNICELL, Inc
Txns:
| Paid exercise price by delivering 764 shares
@ $27.12, valued at
$20.7k
|
|
02/08/2016 |
4
| Seim Robin Gene (Executive VP, Intl. & Manf.) has filed a Form 4 on OMNICELL, Inc
Txns:
| Granted 3,250 shares
@ $0 Granted 10,830 shares
@ $0 Granted 26,120 options to buy
@ $27.7, valued at
$723.5k
|
|
10/25/2013 |
4
| Seim Robin Gene (Executive VP and CFO) has filed a Form 4 on OMNICELL, Inc
Txns:
| Sold 7,664 shares
@ $24.5, valued at
$187.8k
Exercised 7,664 options to buy
@ $16.7, valued at
$128k
|
|
10/23/2013 |
4
| Seim Robin Gene (Executive VP and CFO) has filed a Form 4 on OMNICELL, Inc
Txns:
| Sold 9,349 shares
@ $23.76, valued at
$222.1k
Bought 146 shares
@ $24.5, valued at
$3.6k
Exercised 9,349 options to buy
@ $14.1, valued at
$131.8k
Exercised 146 options to buy
@ $16.7, valued at
$2.4k
|
|
06/06/2013 |
4
| Seim Robin Gene (Executive VP and CFO) has filed a Form 4 on OMNICELL, Inc
Txns:
| Sold 5,000 shares
@ $18.77, valued at
$93.9k
|
|
|
|
|